CTX.TO
Crescita Therapeutics Inc
Price:  
0.56 
CAD
Volume:  
25,000.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CTX.TO WACC - Weighted Average Cost of Capital

The WACC of Crescita Therapeutics Inc (CTX.TO) is 6.3%.

The Cost of Equity of Crescita Therapeutics Inc (CTX.TO) is 6.45%.
The Cost of Debt of Crescita Therapeutics Inc (CTX.TO) is 7.30%.

Range Selected
Cost of equity 5.30% - 7.60% 6.45%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 7.00% - 7.60% 7.30%
WACC 5.3% - 7.4% 6.3%
WACC

CTX.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.41 0.56
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.30% 7.60%
Tax rate 25.90% 26.50%
Debt/Equity ratio 0.12 0.12
Cost of debt 7.00% 7.60%
After-tax WACC 5.3% 7.4%
Selected WACC 6.3%